Alexion Pharm Inc
(ALXN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,964,500 | 2,685,500 | 1,365,500 | 584,400 | 966,000 |
| Marketable Securities | 34,900 | 64,000 | 198,300 | 889,700 | 327,400 |
| Receivables | 1,409,300 | 1,243,200 | 922,300 | 726,500 | 649,600 |
| Inventories | 775,700 | 627,600 | 472,500 | 460,400 | 374,700 |
| TOTAL | $5,833,000 | $5,076,400 | $3,385,000 | $2,953,900 | $2,578,200 |
| Non-Current Assets | |||||
| PPE Net | 1,238,800 | 1,163,300 | 1,471,500 | 1,325,400 | 1,035,600 |
| Intangibles | 8,102,500 | 8,381,700 | 8,678,700 | 8,991,800 | 9,340,500 |
| Other Non-Current Assets | 2,928,700 | 2,923,200 | 396,700 | 312,200 | 299,000 |
| TOTAL | $12,270,000 | $12,468,200 | $10,546,900 | $10,629,400 | $10,675,100 |
| Total Assets | $18,103,000 | $17,544,600 | $13,931,900 | $13,583,300 | $13,253,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 142,400 | 126,700 | 93,800 | 167,400 | 167,000 |
| Accounts payable and accrued liabilities | 118,600 | 74,000 | 698,200 | 710,200 | 64,100 |
| Accrued Expenses | 1,084,700 | 892,700 | N/A | N/A | 508,000 |
| Other current liabilities | 279,000 | 100,900 | 132,000 | 74,900 | 47,200 |
| TOTAL | $1,624,700 | $1,194,300 | $1,174,000 | $952,500 | $822,900 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,419,600 | 2,375,000 | 2,501,700 | 2,720,700 | 2,888,100 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 36,600 |
| Other Non-Current Liabilities | 775,300 | 622,100 | 338,800 | 309,100 | 219,600 |
| TOTAL | $4,827,100 | $5,078,500 | $3,592,600 | $3,737,700 | $3,736,600 |
| Total Liabilities | $6,451,800 | $6,272,800 | $4,766,600 | $4,690,200 | $4,559,500 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 219,712 | 221,401 | 223,469 | 221,681 | 224,614 |
| Retained earnings | 5,243,200 | 4,639,800 | 2,325,800 | 2,242,100 | 1,817,600 |
| Other shareholders' equity | -124,900 | -66,700 | -9,600 | -34,300 | 60,200 |
| TOTAL | $11,651,200 | $11,271,800 | $9,165,300 | $8,893,100 | $8,693,800 |
| Total Liabilities And Equity | $18,103,000 | $17,544,600 | $13,931,900 | $13,583,300 | $13,253,300 |